Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation


Sivgin S., Baldane S., DENİZ K., ZARARSIZ G., KAYNAR L., ÇETİN M., ...Daha Fazla

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.16, 2016 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.clml.2016.02.005
  • Dergi Adı: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Allogeneic hematopoietic stem cell transplantation, Ferritin, Hepatic iron overload, Survival, BONE-MARROW-TRANSPLANTATION, TRANSJUGULAR LIVER-BIOPSY, SERUM FERRITIN, RECIPIENTS, DYSFUNCTION, STORES, HEPATOTOXICITY, MUCORMYCOSIS, THALASSEMIA, INFECTIONS
  • Erciyes Üniversitesi Adresli: Evet

Özet

Transfusional iron overload remains a serious problem in alloHSCT setting. Liver is among the most common organs that iron accumulate. The degree of hepatic iron content might be associated with poorer survival in alloHSCT recipients.